A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage.

Front Aging · 2022 · PMC9261343 · PMID 35821844

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

showed a trendp -value = 0.068so close (0.05 < p ≤ 0.1)

Changes in blood plasma in response to GlyNAC supplementation were not significant, although the medium dose showed a trend towards improved glycine status (4.8 g, p -value = 0.068) ( Supplementary Figure S5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.